← USPTO Patent Applications

CLINICAL DERIVATIONS OF AN ALLOGENIC CELL AND THERAPEUTIC USES

Application US20260078347A1 Kind: A1 Mar 19, 2026

Inventors

Amit Patel

Abstract

Various cells, stem cells, and stem cell components, including associated methods of generating and using such cells are provided. In one aspect, for example, an isolated cell that is capable of self-renewal and culture expansion and is obtained from a subepithelial layer of a mammalian umbilical cord tissue. Such an isolated cell expresses at least three cell markers selected from CD29, CD73, CD90, CD166, SSEA4, CD9, CD44, CD146, or CD105, and does not express at least three cell markers selected from CD45, CD34, CD14, CD79, CD106, CD86, CD80, CD19, CD117, Stro-1, or HLA-DR.

CPC Classifications

C12N 5/0682 A61K 35/51 C12N 5/0605 C12N 5/0653 C12N 5/0654 C12N 5/0655 C12N 5/0657

Filing Date

2025-09-22

Application No.

19335129